title: Botulinum toxin for depression: Does patient appearance matter?
authors.affiliation: University of Texas at Austin, Dell Medical School, Austin, Texas; Seton Family of Hospitals, Austin, Texas. Electronic address: jreichenberg@seton.org.
authors.forename: Jason S
authors.initials: JS
authors.lastname: Reichenberg
authors.affiliation: University of Texas at Austin, Dell Medical School, Austin, Texas.
authors.forename: Aaron J
authors.initials: AJ
authors.lastname: Hauptman
authors.affiliation: University of Texas at Austin, Dell Medical School, Austin, Texas; Seton Family of Hospitals, Austin, Texas.
authors.forename: Henry T
authors.initials: HT
authors.lastname: Robertson
authors.affiliation: Chevy Chase Cosmetic Center, Maryland.
authors.forename: Eric
authors.initials: E
authors.lastname: Finzi
authors.affiliation: Center of Mental Health, Hannover Medical School, Germany.
authors.forename: Tillman H C
authors.initials: TH
authors.lastname: Kruger
authors.affiliation: Asklepios Clinic North-Ochsenzoll, Hamburg, Germany.
authors.forename: M Axel
authors.initials: MA
authors.lastname: Wollmer
authors.affiliation: University of Texas at Austin, Dell Medical School, Austin, Texas.
authors.forename: Michelle
authors.initials: M
authors.lastname: Magid
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000175:diagnosis* / Q000188:drug therapy*; D005149:Facial Expression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A